Bioprojet
Records under this name other than the patents Bioprojet holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,266,867 | Piperidinyl monocarboxylic acids as S1P1 receptor agonists Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,076,329 | Histamine H3-receptor ligands and their therapeutic applications Term ended Term ended Jul 4, 2026 · From the USPTO record | Term ended | Term ended Jul 4, 2026 | From the USPTO record |
| US 8,354,430 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine Term ended Term ended Feb 6, 2026 · From the USPTO record | Term ended | Term ended Feb 6, 2026 | From the USPTO record |
| US 8,222,294 | Combinations of an anti emetic agent and an enkephalinase inhibitor Lapsed on the fee record Ended Jul 17, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2024 | From the USPTO record |
| US 7,910,605 | Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications Term ended Term ended Sep 23, 2022 · From the USPTO record | Term ended | Term ended Sep 23, 2022 | From the USPTO record |
| US 6,835,851 | Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids Term ended Term ended Mar 8, 2022 · From the USPTO record | Term ended | Term ended Mar 8, 2022 | From the USPTO record |
| US 6,919,093 | Formulation Term ended Term ended Oct 2, 2021 · From the USPTO record | Term ended | Term ended Oct 2, 2021 | From the USPTO record |
| US RE37,303 | Imidazole compounds and their therapeutic applications Term ended Term ended Apr 6, 2020 · From the USPTO record | Term ended | Term ended Apr 6, 2020 | From the USPTO record |
| US 7,169,928 | Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications Term ended Term ended Feb 2, 2020 · From the USPTO record | Term ended | Term ended Feb 2, 2020 | From the USPTO record |
| US 7,138,413 | Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications Term ended Term ended Jul 29, 2019 · From the USPTO record | Term ended | Term ended Jul 29, 2019 | From the USPTO record |